Simmons & Simmons JWS has advised NSI Ventures and Aviva Ventures on a US$5 million series A investment into Biofourmis, a health-tech company based in Singapore.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.